Develops molecular diagnostic solutions using CRISPR and synthetic biology to enable rapid, accessible DNA and RNA testing.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Sherlock Biosciences focuses on revolutionizing molecular diagnostics through its CRISPR-based and synthetic biology platforms. Their technologies enable rapid, accurate, and affordable testing for DNA and RNA detection, with applications in a variety of healthcare settings. By making diagnostic tools more accessible and decentralized, Sherlock aims to personalize healthcare and improve global health outcomes.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Sherlock Biosciences Management Team
Sherlock Biosciences Valuations & Financials
View real-time NPM data on Sherlock Biosciences stock including daily Sherlock Biosciences stock price estimates, valuation history, and historical share price information. Access Sherlock Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Sherlock Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Sherlock Biosciences? Get in touch to learn more.
Similar Companies
like Sherlock Biosciences
FAQ
We have answers
Sherlock Biosciences stock does not trade on public stock exchanges. Sherlock Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Sherlock Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sherlock Biosciences Stock does not trade on public stock exchanges. In order to sell Sherlock Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Sherlock Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Sherlock Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Sherlock Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Sherlock Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Sherlock Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Sherlock Biosciences is a private company and has not had an IPO. There is currently no Sherlock Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Sherlock Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
